Rodolfo Alejandro

This study follows about 30 people with type 1 diabetes who have already received islet cell transplants. The goal is to see how long the transplanted cells keep working to produce insulin. Participants must take lifelong immunosuppressive drugs to prevent rejection.

This study tests whether the drug Myfortic can prevent the immune system from becoming overly sensitive after an islet transplant has failed in people with type 1 diabetes. The trial involves 18 adults who have lost their islet graft. Participants will take Myfortic alone for two…

This study follows people with type 1 diabetes whose islet transplants have stopped working. Researchers want to learn how the body's immune system changes after the graft is lost. Participants must have had at least one islet transplant without any other organ transplant. No new…